GSK plc (NYSE:GSK) is one of the best growth stocks under $50 to buy now. In a report released on September 4, David Evans ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its litigation by throwing its rival’s next-generation COVID-19 shot into the fold. | ...

GSK plc (NYSE:GSK) is one of the best UK stocks to buy right now. On September 2, TD Cowen analyst Steve Scala maintained a ...

Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production ...

GSK announced today that Arexvy (respiratory syncytial virus vaccine – recombinant, AS01E adjuvanted) will be offered through ...

In 2025, GSK expects to launch five new products/line extensions, including Blenrep, depemokimab (severe asthma and CRSwNP), ...

Certainly! Here is the revised version of the article text with em dashes replaced and improved formatting: If you have been eyeing GSK stock and wondering whether now is the time to act, you are ...

The Key Antibody Drug Conjugates Companies in the market include - Bristol Myers Squibb, GSK, MBrace therapeutics, Oxford ...

GSK PLC closed 12.58% short of its 52-week high of £16.79, which the company achieved on September 9th.